Company profile: Direct Flow Medical
1.1 - Company Overview
Company description
- Provider of medical implants used in the treatment of aortic and heart valve diseases.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Direct Flow Medical
Imricor
HQ: United States
Website
- Description: Provider of MRI-compatible electrophysiology tools for treating cardiac arrhythmias, including the Vision-MR Ablation Catheter for active MRI scanning with real-time visualization and individualized treatment without radiation exposure; the Advantage-MR EP Recorder/Stimulator for displaying and recording intracardiac electrograms, pacing, and tip temperature monitoring during iCMR procedures; and the Vision-MR Dispersive Electrode to minimize eddy currents during MR scanning.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Imricor company profile →
Nectero Medical
HQ: United States
Website
- Description: Provider of a minimally invasive treatment to stabilize growth and prevent rupture of small to mid-sized abdominal aortic aneurysms through the Nectero EAST® System, which uses a dual-balloon catheter to deliver a stabilizer mixture to strengthen the aortic wall; includes the stAAAble Trial to evaluate safety and efficacy in patients with infrarenal abdominal aortic aneurysms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nectero Medical company profile →
diaDexus
HQ: United States
Website
- Description: Provider of novel, patent-protected diagnostic products with high clinical value, focused on the discovery, development and commercialization of diagnostics. The company's lead product, the PLAC Test, measures Lp-PLA2 (lipoprotein-associated phospholipase A2), a vascular-specific inflammatory enzyme.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full diaDexus company profile →
Laminar
HQ: United States
Website
- Description: Provider of devices that eliminate the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Laminar company profile →
Marea Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology therapies leveraging human genetics to develop next-generation treatments for cardiometabolic diseases. Pipeline includes MAR001, a monoclonal antibody targeting ANGPTL4 to reduce remnant cholesterol and triglycerides and improve adipose tissue function (Phase 2), MAR002, an anti-growth hormone receptor antibody for acromegaly, and undisclosed discovery programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Marea Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Direct Flow Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Direct Flow Medical
2.2 - Growth funds investing in similar companies to Direct Flow Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Direct Flow Medical
4.2 - Public trading comparable groups for Direct Flow Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →